101 related articles for article (PubMed ID: 18236388)
1. Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: a rare indication for liver retransplantation.
Snape K; Izatt L; Ross P; Ellis D; Mann K; O'Grady J
Liver Transpl; 2008 Feb; 14(2):155-8. PubMed ID: 18236388
[No Abstract] [Full Text] [Related]
2. Death from donor-transmitted malignancy despite emergency liver retransplantation.
Lipshutz GS; Baxter-Lowe LA; Nguyen T; Jones KD; Ascher NL; Feng S
Liver Transpl; 2003 Oct; 9(10):1102-7. PubMed ID: 14526407
[TBL] [Abstract][Full Text] [Related]
3. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics.
Baehner R; Magrane G; Balassanian R; Chang C; Millward C; Wakil AE; Osorio RW; Waldman FM
Hum Pathol; 2000 Nov; 31(11):1425-9. PubMed ID: 11112220
[TBL] [Abstract][Full Text] [Related]
4. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
Kakar S; Burgart LJ; Charlton MR; Saito Y; Halling K; Thibodeau SN
Hum Pathol; 2002 Apr; 33(4):435-6. PubMed ID: 12055679
[TBL] [Abstract][Full Text] [Related]
5. Liver retransplantation for hepatitis C: seeing is believing.
Rosen HR
Liver Transpl; 2007 Sep; 13(9):1217-8. PubMed ID: 17763404
[No Abstract] [Full Text] [Related]
6. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
7. Endovascular treatment of supratruncal aortic hemorrhage following liver transplantation as a bridging procedure for hepatic retransplantation.
Heidenhain C; Gerlach U; Gebauer B; Pratschke J; Neuhaus P; Puhl G
Liver Transpl; 2009 Mar; 15(3):347-9. PubMed ID: 19243000
[No Abstract] [Full Text] [Related]
8. Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature.
Kim B; Woreta T; Chen PH; Limketkai B; Singer A; Dagher N; Cameron A; Lin MT; Kamel I; Gurakar A
Dig Dis Sci; 2013 May; 58(5):1185-90. PubMed ID: 23242807
[TBL] [Abstract][Full Text] [Related]
9. Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.
Kim JK; Carmody IC; Cohen AJ; Loss GE
Clin Transplant; 2009; 23(4):571-4. PubMed ID: 19681978
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumor in a liver transplant recipient.
Saidi RF; Sepehr A; Cosimi AB; Hertl M
Transplantation; 2008 May; 85(9):1363. PubMed ID: 18475199
[No Abstract] [Full Text] [Related]
11. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
12. Retransplantation for HCV--the view through a broken crystal ball.
Charlton M
Liver Transpl; 2005 Apr; 11(4):382-3. PubMed ID: 15776456
[No Abstract] [Full Text] [Related]
13. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
14. Retransplantation for hepatitis C: what do we really know?
Burton JR; Rosen HR
Liver Transpl; 2004 Dec; 10(12):1504-6. PubMed ID: 15558586
[No Abstract] [Full Text] [Related]
15. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted.
Verna EC; Brown RS
Clin Liver Dis; 2008 Aug; 12(3):637-59, ix-x. PubMed ID: 18625432
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
17. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping.
Donovan JA; Simmons FA; Esrason KT; Jamehdor M; Busuttil RW; Novak JM; Grody WW
Transplantation; 1997 Jan; 63(1):80-4. PubMed ID: 9000665
[TBL] [Abstract][Full Text] [Related]
18. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
19. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
20. Retransplantation for hepatitis C: should it be performed? Yes.
Sheiner PA
Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S18-9. PubMed ID: 9377767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
